Glasgow, United Kingdom

Pim Frederix

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Endo Biologics, Inc.. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pim Frederix: Innovator in Self-Assembling Tripeptides

Introduction

Pim Frederix is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of biochemistry, particularly in the area of self-assembling tripeptides. His innovative work has led to advancements in understanding how tripeptides can form aggregates in solution.

Latest Patents

Frederix holds a patent for "Self-assembling tripeptides." This invention relates to a method of predicting the propensity of tripeptides to form aggregates in solution. The patent also provides tripeptides capable of forming aggregates, as well as nanostructures formed by their self-aggregation. Additionally, it includes pH-responsive aggregates and methods for screening the ability of a tripeptide to form pH-dependent aggregates or gels.

Career Highlights

Pim Frederix is associated with Endo Biologics, Inc., where he continues to explore the potential applications of his research. His work has implications for various fields, including drug delivery and materials science.

Collaborations

Frederix has collaborated with notable colleagues such as Tell Tuttle and Gary Scott. These partnerships have further enriched his research and contributed to the development of innovative solutions in biochemistry.

Conclusion

Pim Frederix is a pioneering inventor whose work on self-assembling tripeptides has opened new avenues in biochemistry. His contributions are vital for advancing our understanding of peptide behavior in solution and have significant potential applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…